136 related articles for article (PubMed ID: 19562876)
1. [The use of recombinant activated factor VII in the treatment of gastrointestinal bleeding following acetylsalicylic acid therapy in a surgical patient].
Vucelić D; Sabljak P; Pesko P; Stojakov D; Keramatollah E; Nenadić B; Pejović D; Velicković D; Bjelović M
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():240-5. PubMed ID: 19562876
[TBL] [Abstract][Full Text] [Related]
2. [The use of recombinant activated factor VII in a patient with uncontrolled bleeding from the gastrointestinal tract].
Vitković R; Petrović I
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():246-8. PubMed ID: 19562877
[TBL] [Abstract][Full Text] [Related]
3. [The use of recombinant activated factor VII to control haemorrhage following exenteration and massive transfusion in coagulopathic patients].
Vucelić D; Kecmanović D; Pavlov M; Ranković V; Masirević V; Djukić A; Palibrk I; Tomasević L; Velicković J; Milovanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():231-9. PubMed ID: 19562875
[TBL] [Abstract][Full Text] [Related]
4. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
5. Successful control of massive gastrointestinal bleeding following umbilical cord blood transplantation (UCBT) by use of recombinant activated factor VII (rFVIIa) and octreotide infusion.
Yadav SP; Sachdeva A; Bhat S; Katewa S
Pediatr Hematol Oncol; 2010 Feb; 27(1):24-30. PubMed ID: 20121552
[TBL] [Abstract][Full Text] [Related]
6. [Successful management of massive gastrointestinal bleeding using recombinant factor VIIa in an elderly patient with respiratory and renal failure].
Liu M; Wang G; Ma Q; Ren J; Guo L; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1215-6. PubMed ID: 25176101
[TBL] [Abstract][Full Text] [Related]
7. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
8. [Our experince with the use of recombinant activated factor VII in postpartum haemorrhage].
Mostić T; Sparić R; Argirović R; Ljubić A; Bozanović T; Arsenijević L; Tomanović-Koković J; Stefanović A
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():204-9. PubMed ID: 19562869
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII in refractory gastrointestinal haemorrhage of unknown aetiology.
Matic I; Titlic M; Lucic I; Mirkovic F; Jurjevic M
Bratisl Lek Listy; 2008; 109(10):438-40. PubMed ID: 19166127
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
11. [Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor].
Antić D; Elezović I; Sufajdzić N; Todorović M; Bila J; Mitrović M; Andjelkovic N
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():218-21. PubMed ID: 19562872
[TBL] [Abstract][Full Text] [Related]
12. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Tofil NM; Winkler MK; Watts RG; Noonan J
Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant activated factor VII for perioperative bleeding].
López R; Aeschlimann N; Carvajal C; Lema G
Rev Med Chil; 2009 Jun; 137(6):837-43. PubMed ID: 19746288
[TBL] [Abstract][Full Text] [Related]
14. [Intraoperative use of recombinant activated factor VII in traumatic unpenetrating liver injury--case report].
Popović D
Srp Arh Celok Lek; 2008 Sep; 136 Suppl 3():249-52. PubMed ID: 19562878
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
Girona E; Borrás-Blasco J; Conesa-García V; Navarro-Ruiz A; Solís J; García-Sepulcre MF; Oliver-García I
South Med J; 2007 Jun; 100(6):601-4. PubMed ID: 17591314
[TBL] [Abstract][Full Text] [Related]
16. Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
Stefanović B; Stefanović B; Mijatović S; Radenković D; Popović N; Sijacki A; Lacković V
Vojnosanit Pregl; 2009 Nov; 66(11):928-32. PubMed ID: 20017427
[TBL] [Abstract][Full Text] [Related]
17. The use of recombinant factor VIIa in liver diseases.
Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures].
Koncar IB; Savić N; Davidović LB; Simić D; Marković D; Sindjelić R
Srp Arh Celok Lek; 2008; 136(7-8):367-72. PubMed ID: 18959171
[TBL] [Abstract][Full Text] [Related]
19. Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
Marson F; Farnia A; Callegher L; Casagrande L; Surdu M; Sarpellon M
Minerva Anestesiol; 2006; 72(7-8):675-82. PubMed ID: 16865086
[TBL] [Abstract][Full Text] [Related]
20. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
